Press Releases
December 19, 2025
RNA Australia appoints experienced biotech leader as CEO
Neutral
EIN Presswire
December 18, 2025
Health And Fitness Club Market Competition Analysis 2025: How Players Are Shaping Growth
Neutral
EIN Presswire
December 19, 2025
Expert team assembled to guide preventive health policy in South Australia
Gov't Institution
Premier of South Australia
Owner: Australian Government
December 18, 2025
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
December 17, 2025
AustraliaMigrate Streamlines Pathways to Address Critical Healthcare Workforce Shortage
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Cartherics to Participate in Prominent Biotech Investor Conferences During JPM Healthcare Week
Neutral
EIN Presswire
December 17, 2025
Integrated Wellness Acquisition Corp. Shareholders Approve Proposed Business Combination with Btab Ecommerce Group, Inc.
Indeterminate
GlobeNewswire, Inc.
December 17, 2025
Vitamin Therapy Demand Surges in Bali as Travelers Embrace a New Travel Wellness Hack
Neutral
EIN Presswire
December 20, 2025
Olympian Doctor & Start-Up Founder Dive Into $2 Million Raise as Cold Therapy Heats Up
Indeterminate
GlobeNewswire, Inc.
December 16, 2025
New Immunotherapy Trial for Advanced Melanoma Actively Recruiting Patients in Queensland, Australia.
Neutral
EIN Presswire
December 15, 2025
Colobbo Launches Australian Platform to Improve Visibility and Profitability in Field and Construction Operations
Neutral
EIN Presswire
December 15, 2025
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
Indeterminate
GlobeNewswire, Inc.
December 14, 2025
Proteomics International Laboratories Ltd (PIQ.AX) PromarkerD Predicts Risk of DKD in Aboriginal Australians
Indeterminate
ABN Newswire
Owner: ABN Newswire
December 9, 2025
Australia Enforces Nationwide Ban on Social Media for Teens
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
December 19, 2025
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
Indeterminate
GlobeNewswire, Inc.
December 12, 2025
Continuing to strengthen South Australia\'s preparedness for H5 bird flu
Gov't Institution
Premier of South Australia
Owner: Australian Government
December 12, 2025
New Health Complaints Commissioner appointed
Gov't Institution
Premier of South Australia
Owner: Australian Government
December 19, 2025
RejuvaKnee Brace Demand Surges as Cold Weather Drives Search for Heated Knee Pain Relief
Indeterminate
GlobeNewswire, Inc.